eGene Inc. Announces Its Strategic Full-Service Distribution Alliance with the Global European-Based HVD Life Science and HVD Biotech Vertriebs-GmbH

eGene Inc. (OTCBB:EGEI), which is in the business of developing, manufacturing and marketing analytical systems and reagents for the global bio-separation and genotyping markets, reports today on its new alliance.

Dr. Udo Henseler, CEO, said: “We are pleased to announce our strategic full service distribution alliance with HVD Life Science and HVD Biotech Vertriebs-GmbH ( www.hvdlifesciences.com ), a highly regarded and successful global full service distributor in the broader fields of Life Sciences and Biotechnology products. HVD associates with innovative companies for distribution of Research and Advanced Diagnostic products and services, and supports customers with exceptional service and technical support when introducing new frontier Lab techniques and methods. With offices in Vienna, Athens, Moscow, Hong Kong, Riyadh, Sharjah and Cairo as well as an extensive network of over 40 partner companies, they are ideally positioned to provide customers with fast and top quality service.” Please refer to the eGene Web site for the regions and the many countries serviced by HVD.

Hermanus van Duyne, managing director of HVD, stated: “We have been impressed by the highly innovative and cost effective Micro-Fluidic technology platform offered by eGene’s HDA-GT12(TM) multi-channel capillary electrophoresis system for a broad range of applications in industrial microbiology and medicine. We believe that it could represent a real breakthrough and an affordable solution for most medium sized Laboratories involved with DNA separation and genotyping. The alliance with HVD Life Science and HVD Biotech represents an important augmentation to our product and marketing programs.”

About eGene Inc.

eGene Inc. offers low-cost, micro-fluidic, miniaturized, digital Genotyping systems, which are critical to the present and future of microbial and biological materials testing applications. The company’s product detects, quantifies, identifies and characterizes micro-organisms at unprecedented specificity and sensitivity, and automates routine and non-routine laboratory and industrial procedures critical to new product development, product safety, quality and productivity. For more information, visit eGene’s Web site at: www.egeneinc.com